+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Treatment of chronic hepatitis C in naive patients with high-dose interferon-alpha2a induction therapy and two different ribavirin doses



Treatment of chronic hepatitis C in naive patients with high-dose interferon-alpha2a induction therapy and two different ribavirin doses



Digestive and Liver Disease 36(5): 367-368




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 050836994

Download citation: RISBibTeXText

PMID: 15191208


Related references

High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive patients with chronic hepatitis C. Hepatology 32(4 Pt 2): 561A, October, 2000

High dose consensus interferon induction therapy together with ribavirin for naive patients with chronic hepatitis C. Hepatology 34(4 Pt 2): 579A, October, 2001

High dose induction therapy with consensus interferon and ribavirin for treatment Naive patients with hepatitis C. Hepatology 36(4 Part 2): 362A, October, 2002

High dose induction therapy with consensus interferon followed by combination therapy with ribavirin for treatment-naive hepatitis C patients. Hepatology 34(4 Pt 2): 581A, October, 2001

Induction treatment with high dose interferon alpha combined with Ribavirin and Amantadine for treatment naive patients with chronic hepatitis C a 2 arm randomised pilot study. Hepatology 36(4 Part 2): 577A, October, 2002

Efficacy and tolerability of pegylated interferon-alpha2a plus ribavirin versus pegylated interferon-alpha2b plus ribavirin in treatment-naive chronic hepatitis C patients. Intervirology 53(3): 146-153, 2010

Interferon alpha2a induction therapy in combination with ribavirin and amantadine in naive patients with chronic HCV infection. Gastroenterology 120(5 Supplement 1): A 409, April, 2001

Treatment of naive chronic hepatitis C patients with induction therapy of interferon plus ribavirin shows similar results to those found with pegylated interferons plus ribavirin therapy. Hepatology 34(4 Pt 2): 587A, October, 2001

Hepatitis C virus dynamics during induction with high PEG-IFN doses and ribavirin compared with low PEG-IFN doses plus ribavirin in naive patients with chronic hepatitis C, genotype 1. Journal of Hepatology 34(Supplement 1): 5, April, 2001

High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C. A multicentric, randomised, controlled trial. Gastroenterologie Clinique et Biologique 30(4): 525-532, 2006

Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. Scandinavian Journal of Gastroenterology 34(2): 194-198, 1999

High-dose interferon-alpha2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-alpha monotherapy. World Journal of Gastroenterology 11(34): 5342-5346, 2005

A RCT of high-dose IFN induction followed by combination therapy with ribavirin in naive patients with chronic hepatitis C. Hepatology 32(4 Pt 2): 363A, October, 2000

A multi-center trial using daily induction dose interferon alpha 2b plus ribavirin followed by daily interferon alpha 2b + ribavirin in patients with chronic hepatitis C who are treatment naive. Hepatology 32(4 Pt 2): 556A, October, 2000

A comparison of standard and induction interferon therapy with and without initial ribavirin in treatment naive patients with chronic hepatitis C. Hepatology 32(4 Pt 2): 364A, October, 2000